Kiniksa Pharmaceuticals International : to Report First Quarter 2026 Financial Results on April 28, 2026

Published: 2026-04-23 17:29:28 ET KNSA

Published on 04/23/2026 at 05:29 pm EDT

LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 28, 2026 at 8:30 a.m. Eastern Time to report its first quarter 2026 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company's website at https://www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.

About KiniksaKiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa's portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit https://www.kiniksa.com.

Every Second Counts!®

Kiniksa Investor & Media Contact Jonathan Kirshenbaum (781) 829-3949 [email protected]

Disclaimer

Kiniksa Pharmaceuticals International plc published this content on April 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 23, 2026 at 21:21 UTC.